Page 2598 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 159 Hematologic Problems in the Surgical Patient 2312.e3

98. Lisman T, Leebeek FW: Hemostatic alterations in liver disease: a review 123. Drummond JC, Petrovitch CT: The massively bleeding patient. Anes-
on pathophysiology, clinical consequences, and treatment. Dig Surg thesiol Clin N A 19:633–649, 2001.
24:250–258, 2007. 124. Borgman MA, Spinella PC, Perkins JG, et al: The ratio of blood
99. Tripodi A, Mannucci PM: The coagulopathy of chronic liver disease. products transfused affects mortality in patients receiving massive
N Engl J Med 365:147–156, 2011. transfusions at a combat support hospital. J Trauma 63:805–813, 2007.
100. Northup PG, McMahon MM, Ruhl AP, et al: Coagulopathy does not 125. Gunter OL, Jr, Au BK, Isbell JM, et al: Optimizing outcomes in damage
fully protect hospitalized cirrhosis patients from peripheral venous control resuscitation: identifying blood product ratios associated with
thromboembolism. Am J Gastroenterol 101:1524–1528, quiz 680, improved survival. J Trauma 65:527–534, 2008.
2006. 126. Holcomb JB, Wade CE, Michalek JE, et al: Increased plasma and
101. Dabbagh O, Oza A, Prakash S, et al: Coagulopathy does not protect platelet to red blood cell ratios improves outcome in 466 massively
against venous thromboembolism in hospitalized patients with chronic transfused civilian trauma patients. Ann Surg 248:447–458, 2008.
liver disease. Chest 137:1145–1149, 2010. 127. Zink KA, Sambasivan CN, Holcomb JB, et al: A high ratio of plasma
102. Sogaard KK, Horvath-Puho E, Gronbaek H, et al: Risk of venous throm- and platelets to packed red blood cells in the first 6 hours of massive
boembolism in patients with liver disease: a nationwide population-based transfusion improves outcomes in a large multicenter study. Am J Surg
case-control study. Am J Gastroenterol 104:96–101, 2009. 197:565–570, discussion 70, 2009.
103. Lisman T, Bakhtiari K, Pereboom IT, et al: Normal to increased throm- 128. Wafaisade A, Maegele M, Lefering R, et al: High plasma to red blood
bin generation in patients undergoing liver transplantation despite cell ratios are associated with lower mortality rates in patients receiving
prolonged conventional coagulation tests. J Hepatol 52:355–361, 2010. multiple transfusion (4</=red blood cell units<10) during acute trauma
104. Gatt A, Riddell A, Calvaruso V, et al: Enhanced thrombin generation resuscitation. J Trauma 70:81–88, discussion 8-9, 2011.
in patients with cirrhosis-induced coagulopathy. J Thromb Haemost 129. Colman RW: Hemostatic complications of cardiopulmonary bypass.
8:1994–2000, 2010. Am J Hematol 48:267–272, 1995.
105. Aldawood A, Arabi Y, Aljumah A, et al: The incidence of venous 130. Gelb AB, Roth RI, Levin J, et al: Changes in blood coagulation during
thromboembolism and practice of deep venous thrombosis prophylaxis and following cardiopulmonary bypass: lack of correlation with clinical
in hospitalized cirrhotic patients. Thromb J 9:1, 2011. bleeding. Am J Clin Pathol 106:87–99, 1996.
106. Caturelli E, Squillante MM, Andriulli A, et al: Fine-needle liver biopsy 131. Mammen EF, Koets MH, Washington BC, et al: Hemostasis changes
in patients with severely impaired coagulation. Liver 13:270–273, during cardiopulmonary bypass surgery. Semin Thromb Hemost
1993. 11:281–292, 1985.
107. Dillon JF, Simpson KJ, Hayes PC: Liver biopsy bleeding time: an 132. Boisclair MD, Lane DA, Philippou H, et al: Mechanisms of throm-
unpredictable event. J Gastroenterol Hepatol 9:269–271, 1994. bin generation during surgery and cardiopulmonary bypass. Blood
108. Ozier Y, Steib A, Ickx B, et al: Haemostatic disorders during liver 82:3350–3357, 1993.
transplantation. Eur J Anaesthesiol 18:208–218, 2001. 133. Zilla P, Fasol R, Groscurth P, et al: Blood platelets in cardiopulmonary
109. Deitcher SR: Interpretation of the international normalised ratio in bypass operations. Recovery occurs after initial stimulation, rather than
patients with liver disease. Lancet 359:47–48, 2002. continual activation. J Thorac Cardiovasc Surg 97:379–388, 1989.
110. Rockey DC, Caldwell SH, Goodman ZD, et al: Liver biopsy. Hepatol- 134. Weerasinghe A, Taylor KM: The platelet in cardiopulmonary bypass.
ogy 49:1017–1044, 2009. Ann Thorac Surg 66:2145–2152, 1998.
111. Abdel-Wahab OI, Healy B, Dzik WH: Effect of fresh-frozen plasma 135. Milas BL, Jobes DR, Gorman RC: Management of bleeding and coagu-
transfusion on prothrombin time and bleeding in patients with mild lopathy after heart surgery. Semin Thorac Cardiovasc Surg 12:326–336,
coagulation abnormalities. Transfusion 46:1279–1285, 2006. 2000.
112. Mannucci PM, Vicente V, Vianello L, et al: Controlled trial of des- 136. Karlsson M, Ternstrom L, Hyllner M, et al: Prophylactic fibrinogen
mopressin in liver cirrhosis and other conditions associated with a infusion reduces bleeding after coronary artery bypass surgery. A pro-
prolonged bleeding time. Blood 67:1148–1153, 1986. spective randomised pilot study. Thromb Hemost 102:137–144, 2009.
113. Adams GL, Manson RJ, Turner I, et al: The balance of thrombosis and 137. Porte RJ: Coagulation and fibrinolysis in orthotopic liver transplanta-
hemorrhage in surgery. Hematol Oncol Clin North Am 21:13–24, 2007. tion: current views and insights. Semin Thromb Hemost 19:191–196,
114. Slichter SJ, Funk DD, Leandoer LE, et al: Kinetic evaluation of haemo- 1993.
stasis during surgery and wound healing. Br J Haematol 27:115–125, 138. Bakker CM, Metselaar HJ, Groenland TN, et al: Increased tissue-
1974. type plasminogen activator activity in orthotopic but not heterotopic
115. Consensus conference: Fresh-frozen plasma. Indications and risks. liver transplantation: the role of the anhepatic period. Hepatology
JAMA 253:551–553, 1985. 16:404–408, 1992.
116. Practice parameter for the use of fresh-frozen plasma, cryoprecipitate, 139. Dmitrewski J, Russell S, Vijeyasingham R, et al: Hematologic problems
and platelets. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets and organ transplantation. World J Surg 20:1160–1165, 1996.
Administration Practice Guidelines Development Task Force of the 140. Porte RJ, Caldwell SH: The role of recombinant factor VIIa in liver
College of American Pathologists. JAMA 271:777–781, 1994. transplantation. Liver Transplant 11:872–874, 2005.
117. Contreras M, Ala FA, Greaves M, et al: Guidelines for the use of 141. Douketis JD, Berger PB, Dunn AS, et al: The perioperative manage-
fresh frozen plasma. British Committee for Standards in Haematology, ment of antithrombotic therapy: American College of Chest Physi-
Working Party of the Blood Transfusion Task Force. Transfus Med cians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
2:57–63, 1992. 133:299s–339s, 2008.
118. O’Shaughnessy DF, Atterbury C, Bolton Maggs P, et al: Guidelines for 142. Skolarus LE, Morgenstern LB, Froehlich JB, et al: Guideline-discordant
the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br periprocedural interruptions in warfarin therapy. Circ Cardiovasc Qual
J Haematol 126:11–28, 2004. Outcomes 4:206–210, 2011.
119. Murray D, Pennell B, Olson J: Variability of prothrombin time and 143. Kearon C, Hirsh J: Management of anticoagulation before and after
activated partial thromboplastin time in the diagnosis of increased elective surgery. N Engl J Med 336:1506–1511, 1997.
surgical bleeding. Transfusion 39:56–62, 1999. 144. Spandorfer J: The management of anticoagulation before and after
120. Bolliger D, Gorlinger K, Tanaka KA: Pathophysiology and treatment of procedures. Med Clin N Am 85:1109–1116, v, 2001.
coagulopathy in massive hemorrhage and hemodilution. Anesthesiology 145. Spyropoulos AC: Bridging therapy and oral anticoagulation: current
113:1205–1219, 2010. and future prospects. Curr Opin Hematol 17:444–449, 2010.
121. Levy JH: Massive transfusion coagulopathy. Semin Hematol 43:S59–S63, 146. Walenga JM, Prechel M, Jeske WP, et al: Unfractionated heparin com-
2006. pared with low-molecular-weight heparin as related to heparin-induced
122. Hiippala ST, Myllyla GJ, Vahtera EM: Hemostatic factors and replace- thrombocytopenia. Curr Opin Pulmon Med 11:385–391, 2005.
ment of major blood loss with plasma-poor red cell concentrates. Anesth 147. O’Donnell MJ, Kearon C, Johnson J, et al: Brief communication:
Analg 81:360–365, 1995. Preoperative anticoagulant activity after bridging low-molecular-weight